96 related articles for article (PubMed ID: 27270651)
1. Age-related increase of thromboxane B2 and risk of cardiovascular disease in atrial fibrillation.
Pastori D; Pignatelli P; Farcomeni A; Nocella C; Bartimoccia S; Carnevale R; Violi F
Oncotarget; 2016 Jun; 7(26):39143-39147. PubMed ID: 27270651
[TBL] [Abstract][Full Text] [Related]
2. Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
Pastori D; Nocella C; Farcomeni A; Bartimoccia S; Santulli M; Vasaturo F; Carnevale R; Menichelli D; Violi F; Pignatelli P;
J Am Coll Cardiol; 2017 Sep; 70(12):1455-1462. PubMed ID: 28911508
[TBL] [Abstract][Full Text] [Related]
3. Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation.
Pastori D; Pignatelli P; Farcomeni A; Cangemi R; Hiatt WR; Bartimoccia S; Nocella C; Vicario T; Bucci T; Carnevale R; Lip GY; Violi F
Am Heart J; 2015 Sep; 170(3):490-7.e1. PubMed ID: 26385032
[TBL] [Abstract][Full Text] [Related]
4. Mediterranean diet reduces thromboxane A2 production in atrial fibrillation patients.
Pignatelli P; Pastori D; Farcomeni A; Nocella C; Bartimoccia S; Vicario T; Bucci T; Carnevale R; Violi F
Clin Nutr; 2015 Oct; 34(5):899-903. PubMed ID: 25288566
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular events occur independently of high on-aspirin platelet reactivity and residual COX-1 activity in stable cardiovascular patients.
Nagatsuka K; Miyata S; Kada A; Kawamura A; Nakagawara J; Furui E; Takiuchi S; Taomoto K; Kario K; Uchiyama S; Saito K; Nagao T; Kitagawa K; Hosomi N; Tanaka K; Kaikita K; Katayama Y; Abumiya T; Nakane H; Wada H; Hattori A; Kimura K; Isshiki T; Nishikawa M; Yamawaki T; Yonemoto N; Okada H; Ogawa H; Minematsu K; Miyata T
Thromb Haemost; 2016 Aug; 116(2):356-68. PubMed ID: 27098431
[TBL] [Abstract][Full Text] [Related]
6. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
[TBL] [Abstract][Full Text] [Related]
7. Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort.
Pastori D; Pignatelli P; Menichelli D; Violi F; Lip GYH
Mayo Clin Proc; 2019 Jul; 94(7):1261-1267. PubMed ID: 30551910
[TBL] [Abstract][Full Text] [Related]
8. Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study.
Pastori D; Carnevale R; Nocella C; Bartimoccia S; Novo M; Cammisotto V; Piconese S; Santulli M; Vasaturo F; Violi F; Pignatelli P;
J Am Heart Assoc; 2018 Nov; 7(22):e009509. PubMed ID: 30571484
[TBL] [Abstract][Full Text] [Related]
9. Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation.
Pastori D; Pignatelli P; Sciacqua A; Perticone M; Violi F; Lip GYH
Int J Cardiol; 2018 Mar; 255():69-73. PubMed ID: 29290420
[TBL] [Abstract][Full Text] [Related]
10. Urinary 11-dehydro-thromboxane B2: a quantitative index of platelet activation in cerebral infarction.
Uyama O; Shimizu S; Nakanishi T; Nakahama H; Takiguchi A; Hayashi Y; Yamamoto S; Sugita M
Intern Med; 1992 Jun; 31(6):735-9. PubMed ID: 1392173
[TBL] [Abstract][Full Text] [Related]
11. Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet.
Pastori D; Carnevale R; Nocella C; Novo M; Santulli M; Cammisotto V; Menichelli D; Pignatelli P; Violi F
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28584074
[TBL] [Abstract][Full Text] [Related]
12. Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease.
Vazzana N; Santilli F; Lattanzio S; Liani M; Giacci L; Del Rosso G; Salvati F; Boccatonda A; Ferroni P; Davì G
Eur J Intern Med; 2016 Sep; 33():74-80. PubMed ID: 27389698
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
[TBL] [Abstract][Full Text] [Related]
14. Aging-Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation.
Pastori D; Pignatelli P; Farcomeni A; Menichelli D; Nocella C; Carnevale R; Violi F
J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27609361
[TBL] [Abstract][Full Text] [Related]
15. Platelet activation and lipid peroxidation in patients with acute ischemic stroke.
van Kooten F; Ciabattoni G; Patrono C; Dippel DW; Koudstaal PJ
Stroke; 1997 Aug; 28(8):1557-63. PubMed ID: 9259748
[TBL] [Abstract][Full Text] [Related]
16. Increased thromboxane metabolites excretion in liver cirrhosis.
Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. A prospective multicenter cohort study.
Menichelli D; Sciacqua A; Cangemi R; Andreozzi P; Del Sole F; Violi F; Pignatelli P; Pastori D;
Int J Clin Pract; 2021 Mar; 75(3):e13771. PubMed ID: 33078565
[TBL] [Abstract][Full Text] [Related]
18. Increased thromboxane biosynthesis in essential thrombocythemia.
Rocca B; Ciabattoni G; Tartaglione R; Cortelazzo S; Barbui T; Patrono C; Landolfi R
Thromb Haemost; 1995 Nov; 74(5):1225-30. PubMed ID: 8607099
[TBL] [Abstract][Full Text] [Related]
19. Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Platelets; 2011; 22(3):188-95. PubMed ID: 21231857
[TBL] [Abstract][Full Text] [Related]
20. Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites.
Forastiero R; Martinuzzo M; Carreras LO; Maclouf J
Thromb Haemost; 1998 Jan; 79(1):42-5. PubMed ID: 9459320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]